{"id":"flulavaltm-vb","safety":{"commonSideEffects":[{"rate":"10–30%","effect":"Injection site soreness or erythema"},{"rate":"5–15%","effect":"Myalgia"},{"rate":"5–10%","effect":"Headache"},{"rate":"5–10%","effect":"Fatigue"},{"rate":"<5%","effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) influenza virus antigens from two influenza A subtypes (H1N1 and H3N2) and two influenza B lineages. Upon administration, these antigens trigger both humoral (antibody) and cellular immune responses, priming the immune system to recognize and neutralize circulating influenza viruses during the flu season.","oneSentence":"FluLaval-VB is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:13:01.432Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT01196975","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-10-01","conditions":"Influenza","enrollment":1707}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["FluLavalTM containing the Victoria B flu strain","FluLaval®-VB","Victoria Strain FluLaval vaccine"],"phase":"phase_3","status":"active","brandName":"FluLavalTM-VB","genericName":"FluLavalTM-VB","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Biologic","firstApprovalDate":"","aiSummary":"FluLaval-VB is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}